Caricamento...
Immunomodulation by anticancer cell cycle inhibitors
Cell cycle proteins that are often dysregulated in malignant cells, such as cyclin-dependent kinase 4 (CDK4) and CDK6, have attracted considerable interest as potential targets for cancer therapy. In this context, multiple inhibitors of CDK4 and CDK6 have been developed, including three small molecu...
Salvato in:
| Pubblicato in: | Nat Rev Immunol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7584736/ https://ncbi.nlm.nih.gov/pubmed/32346095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-020-0300-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|